Mankind Pharma Limited — Board Meeting, 13-04-2026: Outcome of Board Meeting
13-04-2026 | 03:23 pm
13-04-2026 | 03:23 pm
Mankind Pharma's Board has approved closing its Sri Lankan wholly-owned subsidiary, Mankind Pharma Lanka. This strategic move follows changed regulatory requirements, making its anticipated business objectives unviable. The subsidiary had no prior operations and is not a material entity.
No comments yet. Be the first to comment!
